Some leukaemia patients may be missing out on new treatments
Patients with an aggressive form of leukaemia, currently ineligible for any type of targeted therapy, may in fact benefit from some of these new drugs, according to new research by Queen Mary University of London.
Jan 9, 2018
0
1